# CE (Chief Engineer) TODO List

**Last Updated**: 2025-12-14 00:30 UTC
**Status**: Phase 9 Complete - Execution Monitoring Phase
**Current Priority**: Monitor Dec 14 preparation day execution

---

## COMPLETED TASKS âœ…

### Phase 1-8: Audit Synthesis & Roadmap Delegation (Dec 13)

- [x] **Direct comprehensive 3-agent audit (EA/BA/QA)**
  - Issued audit directives to EA, BA, QA (Dec 13 20:30)
  - Shared COMPREHENSIVE_REMEDIATION_PLAN_20251213.md
  - Requested gap/deviation/misalignment identification

- [x] **Monitor agent audit progress and deliverables**
  - EA: 6 deliverables submitted (audit complete Dec 13 23:15)
  - BA: 6 deliverables submitted (audit complete Dec 13 22:50)
  - QA: 6 deliverables submitted (audit complete Dec 13 22:45)
  - Total: 18 audit deliverables ingested

- [x] **Review and integrate 18 audit deliverables (Phase 2: Message Ingestion)**
  - EA findings: M008 non-compliance (1,968 tables), M001 ledger missing, M005 incomplete
  - BA findings: Execution readiness 85%, script creation gaps identified
  - QA findings: Validation protocols 89% ready, Option B+B recommendation

- [x] **Validate agent findings for accuracy, priorities, and ML training impact (Phase 3)**
  - Cross-validated all findings across EA/BA/QA reports
  - Verified M008 impact on M005 (blocking relationship confirmed)
  - Assessed ML training impact (table names irrelevant to model accuracy)

- [x] **Optimize agent recommendations using ML-first criteria (Phase 4)**
  - Applied ML-first framework: Does decision impact ML training accuracy?
  - Revised M008 Phase 4C from Option A+A to Option B+B
  - LAG: Consolidate (A) â†’ Rename in place (B) - 2-4 days faster to ML training
  - Views: Grace period (A) â†’ Immediate cutover (B) - saves 2.5h tool creation

- [x] **Synthesize cross-domain findings into unified view (Phase 5)**
  - Identified convergent patterns (all agents recommended M008 priority)
  - Identified divergent patterns (QA Option B+B vs EA Option A+A)
  - Created CE_AUDIT_SYNTHESIS_20251213.md (47 KB comprehensive synthesis)

- [x] **Create ML-first unified roadmap (Phase 6)**
  - Established master timeline (7-9 weeks to ML training readiness)
  - Integrated all mandates (M001, M005, M006, M007, M008)
  - Optimized for TIME TO ML TRAINING (not architectural purity)

- [x] **Reconcile all active phased plans into master roadmap (Phase 7)**
  - Reconciled M008 Phase 4C plan with comprehensive remediation plan
  - Reconciled M005 Phase 2 plan with regression feature mandate
  - Created single source of truth timeline

- [x] **Access and reconcile agents' TODO files with updated roadmap**
  - EA TODO: 8 tasks assigned (Phase 0 + Phase 4C support)
  - BA TODO: 10 tasks assigned (script creation + execution)
  - QA TODO: 9 tasks assigned (protocol review + validation)

- [x] **Delegate roadmap tasks to agents with clear assignments (Phase 8)**
  - EA directive: 20251213_2330_CE-to-EA_ROADMAP_UPDATE_AND_PHASE0_EXECUTION.md (32 KB)
  - BA directive: 20251213_2330_CE-to-BA_ROADMAP_UPDATE_AND_SCRIPT_CREATION.md (28 KB)
  - QA directive: 20251213_2330_CE-to-QA_ROADMAP_UPDATE_AND_VALIDATION_PROTOCOLS.md (26 KB)

- [x] **Solicit clarifying questions from each agent to ensure alignment**
  - EA: 5 clarifying questions issued
  - BA: 5 clarifying questions issued
  - QA: 5 clarifying questions issued

### Phase 9: Agent Response Review & GO Authorization (Dec 13-14)

- [x] **Review and approve all agent clarifying question responses**
  - EA: 5/5 responses approved (Option C/C/A/A/B)
  - BA: 5/5 responses approved (Option A/A/B/B/B) + 3 follow-up questions answered
  - QA: 5/5 responses approved (Hybrid/A/Hybrid/Tiered/C)
  - Validated perfect alignment with user priorities (best long-term outcome > cost > time)

- [x] **Issue final GO authorization for Dec 14 08:00 UTC execution (Phase 9 complete)**
  - Created 20251214_0030_CE-to-ALL_FINAL_GO_AUTHORIZATION.md (50+ KB)
  - Authorized EA Phase 0 (intelligence updates, deprecation, COV investigation, LAG exception)
  - Authorized BA script creation (COV/LAG/VAR scripts, testing, dry-run, documentation)
  - Authorized QA protocol review (tool validation, checklist, EA/BA validation)
  - Confirmed daily standup (09:00 UTC Dec 15-22)
  - Confirmed script approval meeting (18:00 UTC Dec 14, Hybrid format)

---

## CURRENT TASKS (IN PROGRESS) ðŸ”„

### Monitor Dec 14 Preparation Day Execution

**Timeline**: Dec 14, 08:00-18:00 UTC (10 hours)
**Status**: PENDING (execution starts Dec 14 08:00 UTC)

**EA Phase 0 Monitoring**:
- [ ] 08:00-10:00: Intelligence file updates (feature_catalogue.json, BQX_ML_V3_FEATURE_INVENTORY.md)
- [ ] 10:00-11:00: Deprecate old M008 plan
- [ ] 11:00-17:00: COV surplus investigation (882 tables categorization)
- [ ] 17:00-18:00: LAG exception documentation (NAMING_STANDARD_MANDATE.md)
- [ ] 18:00: EA Phase 0 deliverables review

**BA Script Creation Monitoring**:
- [ ] 08:00-12:00: COV script development (variant detection, batch execution, rollback CSV)
- [ ] 08:00-10:00 (parallel): VAR strategy assessment
- [ ] 10:00-11:00 (parallel): LAG mapping generation + review
- [ ] 12:00-16:00: Testing and dry-run (sample tables)
- [ ] 16:00-17:00: Documentation and approval meeting prep
- [ ] 17:00: BA written submission review (scripts, dry-run results, VAR strategy, LAG CSV)

**QA Protocol Review Monitoring**:
- [ ] 08:00-10:00: M008 validation tool review (audit_m008_table_compliance.py)
- [ ] 10:00-11:00: Batch validation checklist creation
- [ ] 11:00-12:00: EA Phase 0 validation - Part 1 (intelligence files)
- [ ] 12:00-13:00: EA Phase 0 validation - Part 2 (COV investigation report)
- [ ] 17:00-18:00: BA script validation (GO/NO-GO recommendation)

**CE Actions**:
- [ ] Check agent inboxes 3x daily (09:00, 14:00, 18:00 UTC)
- [ ] Respond to any Tier 2 escalations within 30 min
- [ ] Review BA written materials (17:00-18:00 UTC)
- [ ] Review EA Phase 0 deliverables (18:00 UTC)

---

## PENDING TASKS (NEXT) ðŸ“‹

### Attend Script Approval Meeting (Dec 14, 18:00 UTC)

**Format**: Hybrid (Written submission 17:00 + Sync meeting 18:00)
**Duration**: 30 min
**Attendees**: CE, BA, QA

**Agenda**:
- [ ] Review BA written materials (COV script, dry-run results, VAR strategy, LAG CSV)
- [ ] BA demonstrates dry-run results
- [ ] QA presents GO/NO-GO recommendation
- [ ] CE asks clarifying questions
- [ ] CE makes GO/NO-GO decision for Dec 15 M008 Phase 4C execution

**Decision Outcomes**:
- **GO**: Dec 15 08:00 UTC M008 Phase 4C execution begins
- **NO-GO**: BA addresses issues, resubmits Dec 15 AM, new approval meeting Dec 15 12:00 UTC

---

### Monitor M008 Phase 4C Execution (Dec 15-22)

**Timeline**: 8 days (Dec 15-22)
**Scope**: 1,968 tables renamed (COV + LAG + VAR + Primary violations)

**Daily Standup Attendance** (09:00 UTC, 15 min):
- [ ] Dec 15: Day 1 standup (COV/LAG/VAR execution plan)
- [ ] Dec 16: Day 2 standup (primary violations start, EA CSV delivery)
- [ ] Dec 17: Day 3 standup
- [ ] Dec 18: Day 4 standup
- [ ] Dec 19: Day 5 standup
- [ ] Dec 20: Day 6 standup
- [ ] Dec 21: Day 7 standup
- [ ] Dec 22: Day 8 standup (final batches)

**Monitoring Responsibilities**:
- [ ] Respond to Tier 2 escalations within 30 min (QA â†’ CE â†’ decision)
- [ ] Review EOD summary reports daily (18:00 UTC)
- [ ] Track progress against plan (1,968 tables total)
- [ ] Resolve blockers as they arise

**Key Milestones**:
- [ ] Dec 15 EOD: COV (1,596) + LAG (224) + VAR (7) complete = 1,827 tables
- [ ] Dec 16 12:00: EA delivers primary violations CSV (364 tables)
- [ ] Dec 22 EOD: All 1,968 tables renamed (M008 Phase 4C complete)

---

## FUTURE TASKS (BACKLOG) ðŸ”®

### M008 Phase 1 Certification (Dec 23)
- [ ] Review QA automated audit results (all 5,817 tables)
- [ ] Review QA manual spot-check results (50-100 tables)
- [ ] Review M008_PHASE_1_CERTIFICATE.md
- [ ] Approve QA sign-off: "Certified 100% M008 compliance, ready for M005 Phase 2"

### M005 Phase 2: Regression Feature Schema Updates (Dec 30 - Feb 21)
- [ ] TRI schema update (Dec 30 - Jan 17, 3 weeks)
- [ ] COV schema update (Jan 18 - Feb 7, 3 weeks)
- [ ] VAR schema update (Feb 8-21, 2 weeks)
- [ ] Coverage verification (Feb 22-28, 1 week)

### M001 Feature Ledger Creation (Mar 1-21)
- [ ] Feature ledger architecture design
- [ ] Feature ledger implementation
- [ ] Feature ledger validation

---

## KEY DECISIONS MADE

### M008 Phase 4C Strategy (Dec 13)
- **Decision**: Option B+B (LAG rename in place + no views)
- **Rationale**: ML-first optimization - 2-4 days faster to ML training, same accuracy outcome
- **Impact**: $5-10 cost savings, simpler execution, lower risk

### Daily Standup Schedule (Dec 14)
- **Decision**: 09:00 UTC Dec 15-22 (8 days)
- **Format**: Structured standup (15 min, CE/EA/BA/QA)
- **Rationale**: Daily visibility without overload

### Script Approval Meeting Format (Dec 14)
- **Decision**: Hybrid (written 17:00 + sync 18:00)
- **Rationale**: Balance thoroughness (written review) with efficiency (sync for clarifications)

### Validation Protocols (Dec 14)
- **Row count**: 100% validation (zero data loss guarantee, <$0.50 cost)
- **M008 compliance**: Hybrid (first batch 100% â†’ remaining 20% sampling)
- **Authority**: Tiered (QA Tier 1 halt / CE Tier 2 decide / QA+BA Tier 3 resolve)
- **Reporting**: Daily standup + exception + EOD summary

---

## COMMITMENTS

**CE Commitments**:
- âœ… Attend all 8 daily standups (Dec 15-22, 09:00 UTC)
- âœ… Attend script approval meeting (Dec 14, 18:00 UTC)
- âœ… Respond to Tier 2 escalations within 30 min
- âœ… Review EOD summary reports daily (18:00 UTC)
- âœ… Monitor agent communications 3x daily (09:00, 14:00, 18:00 UTC)

**Agent Commitments Acknowledged**:
- EA: Phase 0 complete by 18:00 UTC Dec 14, primary violations CSV by Dec 16 12:00 UTC
- BA: Scripts + dry-run + documentation complete by 17:00 UTC Dec 14
- QA: Protocol review + validations complete by 18:00 UTC Dec 14, GO/NO-GO recommendation

---

## NOTES

**User Priorities** (from system reminder):
1. **Highest priority**: Best long-term outcome
2. **2nd priority**: Cost
3. **3rd priority**: Time
4. **Philosophy**: Long-term performance > quick fixes and shortcuts

**ML-First Optimization Principle**:
- Question: Does decision impact ML training accuracy?
- Question: Which option optimizes TIME TO ML TRAINING?
- Analysis: Table names don't affect feature values or model performance
- Result: Option B+B is 2-4 days faster to ML training with same accuracy outcome

**Ultimate Goal**: 95%+ model accuracy across 588 models (28 pairs Ã— 7 horizons Ã— 3 ensemble)

---

**Status**: Phase 9 Complete âœ… | Next: Monitor Dec 14 execution
**Timeline**: 7-9 weeks to ML training readiness (optimized from 9-11 weeks)
**Cost**: $50-80 total (optimized from $55-90)
